Affinity and specificity of ciprofloxacin-bovine serum albumin interactions: spectroscopic approach.
Fluorescence spectroscopy in combination with UV-Vis absorption spectroscopy were employed to investigate the binding of an antibacterial drug Ciprofloxacin (CPFX) to bovine serum albumin (BSA) under the physiological conditions. In the discussion of the quenching mechanism, it was proved that the fluorescence quenching of BSA by CPFX is a result of the formation of CPFX-BSA complex. Binding parameters were determined using the modified Stern-Volmer equation and Scatchard equation to provide a measure of the binding affinity between CPFX and BSA. The results of thermodynamic parameters DeltaG, DeltaH, DeltaS, at different temperatures indicate that the electrostatic interactions play a major role for CPFX-BSA association. Site marker competitive experiments indicated that the binding of CPFX to BSA primarily took place in site I. Furthermore, the effect of metal ions to CPFX-BSA system was studied, and the distance r between donor (BSA) and acceptor (CPFX) was obtained according to fluorescence resonance energy transfer (FRET). The conformation of BSA upon CPFX binding was evaluated by measuring synchronous fluorescence properties of the CPFX-BSA complex.
Hu
Yan-Jun
YJ
Department of Chemistry, Hubei Normal University, Huangshi, People's Republic of China. yjhu@263.net
Ou-Yang
Yu
Y
Zhang
Yue
Y
Liu
Yi
Y
D000465:Algorithms; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D002939:Ciprofloxacin / Q000737:chemistry* / Q000378:metabolism*; D031541:Fluorescence Resonance Energy Transfer / Q000379:methods*; D011485:Protein Binding; D012710:Serum Albumin, Bovine / Q000737:chemistry* / Q000378:metabolism*; D013696:Temperature; D013816:Thermodynamics
D012710:Serum Albumin, Bovine; D002939:Ciprofloxacin
J Pharm Biomed Anal. 2006 May 3;41(2):393-9
16413740
Int J Antimicrob Agents. 2009 Jun;33(6):579-82
19232480
Regul Toxicol Pharmacol. 2009 Apr;53(3):209-16
19545513
Environ Sci Technol. 2008 Nov 15;42(22):8270-6
19068805
Biochemistry. 1971 Aug 17;10(17):3254-63
5119250
Biomacromolecules. 2008 Mar;9(3):812-7
18266320
J Agric Food Chem. 2008 Oct 8;56(19):8838-43
18771271
Mol Pharmacol. 1976 Nov;12(6):1052-61
1004490
Adv Protein Chem. 1994;45:153-203
8154369
Biochim Biophys Acta. 2005 Feb 11;1722(1):15-21
15715992
J Phys Chem B. 2008 Dec 25;112(51):16793-801
19367911
J Med Chem. 2008 Apr 10;51(7):2009-17
18348514
Eur J Biochem. 1994 Dec 15;226(3):1049-52
7813459
J Am Chem Soc. 2006 May 10;128(18):6024-5
16669657
J Pharm Biomed Anal. 2010 Feb 5;51(3):768-73
19853398
Environ Sci Technol. 2007 May 1;41(9):3153-8
17539519
Biochemistry. 1981 May 26;20(11):3096-102
7248271
Mol Pharmacol. 1975 Nov;11(6):824-32
1207674
Int J Antimicrob Agents. 2009 Sep;34(3):260-4
19362452
Environ Sci Technol. 2008 Jul 1;42(13):4889-95
18678022
Int J Antimicrob Agents. 2008 Feb;31(2):130-4
18060746
J Am Chem Soc. 2009 Aug 26;131(33):11644-5
19645470
J Med Chem. 2001 Dec 6;44(25):4370-8
11728183
Int J Antimicrob Agents. 2009 Sep;34(3):215-9
19375896
Biomacromolecules. 2009 Mar 9;10(3):517-21
19173654
J Biol Chem. 2000 Feb 4;275(5):3042-50
10652284
Nature. 1992 Jul 16;358(6383):209-15
1630489
Eur J Pharmacol. 2009 Apr 1;607(1-3):23-6
19232343